Symptomatic MERS-CoV infection reduces the risk of future COVID-19 disease; a retrospective cohort study
Description
CONCLUSIONS: The current findings may indicate a partial cross-immunity, where patients with symptomatic MERS-CoV have a lower risk of future COVID-19 infection and related hospitalization. The present results may need further examination nationally
